Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis. by Bruy&#232 et al.
ERRATUM
Erratum to: Can We Identify Patients with High Risk
of Osteoarthritis Progression Who Will Respond to Treatment?
A Focus on Epidemiology and Phenotype of Osteoarthritis
Olivier Bruye`re1 • Cyrus Cooper2,3 • Nigel Arden2,3 • Jaime Branco4 •
Maria Luisa Brandi5 • Gabriel Herrero-Beaumont6 • Francis Berenbaum7 •
Elaine Dennison2 • Jean-Pierre Devogelaer8 • Marc Hochberg9 •
John Kanis10 • Andrea Laslop11 • Tim McAlindon12 • Susanne Reiter13 •
Pascal Richette14 • Rene´ Rizzoli15 • Jean-Yves Reginster1
Published online: 27 March 2017
 Springer International Publishing Switzerland 2017
Erratum to: Drugs Aging (2015) 32:179–187
DOI 10.1007/s40266-015-0243-3
In the Original publication the affiliation for J. Kanis was
incorrectly published.
This previously read: WHO Collaborating Centre for
Metabolic Bone Diseases, University of Sheffield Medical
School, Sheffield, UK.
Should read: Centre for Metabolic Bone Diseases,
University of Sheffield Medical School, Sheffield, UK.
The online version of the original article can be found under
doi:10.1007/s40266-015-0243-3.
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